Kailen Mark
2025–2025 OpenAlex profile ↗
Reproducibility track record
1
assessed papers
73/100
mean reproducibility
0
reproduced (C1–C2)
0
flagged
0
total citations
flag rate:
0%
(0/1)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 0
last author: 0
Topics
—
Funders
—
Frequent co-authors
Alexander B. Kim 1Stacey Rentschler 1Mary C. Fulbright 1Grant A. Challen 1Sandra E. Dunn 1Fan He 1Li Ding 1Daniel A.C. Fisher 1Jingxian Liu 1LaYow Yu 1
Institutions
Washington University in St. Louis 1Stanford University 1James S. McDonnell Foundation 1Quantum Design (United States) 1
Geography (author institutions)
US 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (1)
Complete publication record (12)
Request a reproduction →1 assessed by us (0 reproduced) · 11 not yet assessed — every PubMed paper on record, linked below.
-
Selective targeting of RSK signaling with PMD-026 suppresses FLT3-activated acute myeloid leukemia while sparing normal hematopoiesis ↗Leukemia · 2026 · PMID 42380665not yet assessed
-
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemiaNature Communications · 2025 · PMID 39820365L1 73/100
-
Abstract 5594: Targeting ribosomal S6 kinase for the treatment of pediatric acute leukemia ↗Cancer Research · 2025not yet assessed
-
Abstract 708: Phase I clinical trial to target oxidative phosphorylation and CREB for children and young adults with relapsed or refractory AML ↗Cancer Research · 2025not yet assessed
-
not yet assessed
-
not yet assessed
-
Activation of nemo-like kinase in diamond blackfan anemia suppresses early erythropoiesis by preventing mitochondrial biogenesis ↗Journal of Biological Chemistry · 2024 · PMID 38992436not yet assessed
-
Repurposing Niclosamide for Treatment of Acute Myeloid Leukemia and Other Diseases ↗Pharmaceutical science. · 2024not yet assessed
-
not yet assessed
-
Niclosamide Inhibits Proliferation of Leukemia Cells and Synergizes with Chemotherapy ↗Blood · 2022not yet assessed
-
not yet assessed
-
RSK Isoforms in Acute Myeloid Leukemia ↗Biomedicines · 2021 · PMID 34202904not yet assessed
Full bibliography from OpenAlex; reproducibility verdicts matched by PMID.
Author attribution follows OpenAlex disambiguation, which is imperfect — a researcher's papers can be split across profiles or mixed with a namesake.
No ORCID on record to anchor it (≈⅓ of researchers have none), so this rests on name disambiguation alone. See every “Mark K” paper on PubMed ↗